SEARCH

SEARCH BY CITATION

References

  • Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT & Wittert GA. (2011) Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 96, 30073019.
  • Bartalena L, Bogazzi F, Brogioni S, Grasso L & Martino E. (1998) Role of cytokines in the pathogenesis of the euthyroid sick syndrome. Eur J Endocrinol 138, 603614.
  • Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, Eder R, Tennstedt S, Ulloor J, Zhang A, Choong K, Lakshman KM, Mazer NA, Miciek R, Krasnoff J, Elmi A, Knapp PE, Brooks B, Appleman E, Aggarwal S, Bhasin G, Hede-Brierley L, Bhatia A, Collins L, LeBrasseur N, Fiore LD, Bhasin S. (2010) Adverse events associated with testosterone administration. N Engl J Med 363, 109122.
  • Boddi V, Corona G, Fisher AD, Mannucci E, Ricca V, Sforza A, Forti G & Maggi M. (2012) “It takes two to tango”: the relational domain in a cohort of subjects with erectile dysfunction. J Sex Med 9, 31263136.
  • Buvat J, Maggi M, Guay A & Torres LO. (2013) Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 10, 245284.
  • Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL & Bhasin S. (2005) Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 60, 14511457.
  • Corona G, Petrone L, Mannucci E, Magini A, Lotti F, Ricca V, Chiarini V, Forti G & Maggi M. (2006a) Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple sexual dysfunction. J Androl 27, 795801.
  • Corona G, Mannucci E, Petrone L, Balercia G, Fisher AD, Chiarini V, Forti G & Maggi M. (2006b) ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction. J Sex Med 3, 706715.
  • Corona G, Fagioli G, Mannucci E, Romeo A, Rossi M, Lotti F, Sforza A, Morittu S, Chiarini V, Casella G, Di Pasquale G, Bandini E, Forti G & Maggi M. (2008) Penile doppler ultrasound in patients with erectile dysfunction (ED): role of peak systolic velocity measured in the flaccid state in predicting arteriogenic ED and silent coronary artery disease. J Sex Med 5, 26232634.
  • Corona G, Mannucci E, Ricca V, Lotti F, Boddi V, Bandini E, Balercia G, Forti G & Maggi M. (2009a) The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction. Int J Androl 32, 720728.
  • Corona G, Mannucci E, Lotti F, Fisher AD, Bandini E, Balercia G, Forti G & Maggi M. (2009b) Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. J Sex Med 6, 285293.
  • Corona G, Monami M, Boddi V, Cameron-Smith M, Lotti F, de Vita G, Melani C, Balzi D, Sforza A, Forti G, Mannucci E & Maggi M. (2010a) Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. J Sex Med 7, 19181927.
  • Corona G, Monami M, Boddi V, Cameron-Smith M, Fisher AD, de Vita G, Melani C, Balzi D, Sforza A, Forti G, Mannucci E & Maggi M. (2010b) Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction. J Sex Med 7, 15571564.
  • Corona G, Rastrelli G, Morelli A, Vignozzi L, Mannucci E & Maggi M. (2011a) Hypogonadism and metabolic syndrome. J Endocrinol Invest 2011, 557567.
  • Corona G, Rastrelli G, Vignozzi L, Mannucci E & Maggi M. (2011b) Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab 25, 337353.
  • Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A, Forti G, Mannucci E & Maggi M. (2011c) Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol 165, 687701.
  • Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, Lenzi A, Forti G, Mannucci E & Maggi M. (2011d) Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl 34, 528540.
  • Corona G, Rastrelli G, Forti G & Maggi M. (2011e) Update in testosterone therapy for men. J Sex Med 8, 639654.
  • Corona G, Rastrelli G, Monami M, Melani C, Balzi D, Sforza A, Forti G, Mannucci E & Maggi M. (2011f) Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction. J Sex Med 8, 20982105.
  • Corona G, Rastrelli G, Vignozzi L, Mannucci E & Maggi M. (2012a) How to recognize late-onset hypogonadism in men with sexual dysfunction. Asian J Androl 2012, 251259.
  • Corona G, Ricca V, Bandini E, Rastrelli G, Casale H, Jannini EA, Sforza A, Forti G, Mannucci E & Maggi M. (2012b) SIEDY scale 3, a new instrument to detect psychological component in subjects with erectile dysfunction. J Sex Med 9, 20172026.
  • Corona G, Rastrelli G & Maggi M. (2013a) Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. Best Pract Res Clin Endocrinol Metab 27, 557579.
  • Corona G, Rastrelli G, Ricca V, Jannini EA, Vignozzi L, Monami M, Sforza A, Forti G, Mannucci E, Maggi M. (2013b) Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction. J Sex Med 10, 10741089.
  • Corona G, Vignozzi L, Sforza A & Maggi M. (2013c) Risks and benefits of late onset hypogonadism treatment: an expert opinion. World J Mens Health 31, 103125.
  • Dong JY, Zhang YH & Qin LQ. (2011) Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 58, 13781385.
  • Fernández-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, Agrwal N, Elamin MB, Gallegos-Orozco JF, Wang AT, Erwin PJ, Bhasin S & Montori VM. (2010) Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 95, 25602575.
  • Finkle WD, Greenland S & Ridgeway GK, Adams JL, Frasco MA, Cook MB, Fraumeni JF Jr, Hoover RN. (2014) Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS ONE 9, e85805.
  • Haddad RM, Kennedy CC, Caples SM, Tracz MJ, Boloña ER, Sideras K, Uraga MV, Erwin PJ & Montori VM. (2007) Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 82, 2939.
  • Hamilton JB & Mestler GE. (1969) Mortality and survival: comparison of eunuchs with intact men and women in a mentally retarded population. J Gerontol 24, 395411.
  • Hatzichristou D, Rosen R, Derogatis L, Meuleman E, O'Leary M, Vardi Y, Low WY, De Zava SM & Symonds T. (2010) Clinical evaluation and symptom scales in men and women with sexual dysfunction. In: Sexual Medicine: Sexual Dysfunctions in Men and Women. The 3rd International Consultation on Sexual Medicine (eds F Montorsi, R Basson, G Adaikan, E Becher, A Clayton, F Giuliano, S Khoury & I Sharlip), pp. 229280. Health Publication Ltd, Paris.
  • Huhtaniemi I & Forti G. (2011) Male late-onset hypogonadism: pathogenesis, diagnosis and treatment. Nat Rev Urol 8, 335344.
  • Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, L'Abbate A & Donato L. (2003) Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 107, 708713.
  • Lindau ST & Gavrilova N. (2010) Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing. BMJ 340, c810.
  • McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann MC & Harris AD. (2005) Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibioticresistant organisms. Am J Epidemiol 161, 483493.
  • Min KJ, Lee CK & Park HN. (2012) The lifespan of Korean eunuchs. Curr Biol 22, R792R793.
  • Muraleedharan V, Marsh H, Kapoor D, Channer KS & Jones TH. (2013) Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. Eur J Endocrinol 169, 725733.
  • Nieschlag E, Nieschlag S & Behre HM. (1993) Lifespan and testosterone. Nature 366, 215.
  • Palmieri L, Panico S, Vanuzzo D, Ferrario M, Pilotto L, Sega R, Cesana G, Giampaoli S; Gruppo di Ricerca del Progetto CUORE (2004) Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score. Ann Ist Super Sanita 40, 393399.
  • Petrone L, Mannucci E, Corona G, Bartolini M, Forti G, Giommi R & Maggi M. (2003) Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction. Int J Impot Res 15, 210220.
  • Rastrelli G, Corona G, Lotti F, Boddi V, Mannucci E & Maggi M. (2013). Relationship of testis size and LH levels with incidence of major adverse cardiovascular events in older men with sexual dysfunction. J Sex Med 10, 27612773.
  • Ruige JB, Mahmoud AM, De Bacquer D & Kaufman JM. (2011) Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart 97, 870875.
  • Schipf S, Haring R, Friedrich N, Nauck M, Lau K, Alte D, Stang A, Völzke H & Wallaschofski H. (2011) Low total testosterone is associated with increased risk of incident type 2 diabetes mellitus in men: results from the Study of Health in Pomerania (SHIP). Aging Male 14, 168175.
  • Shores MM, Smith NL, Forsberg CW, Anawalt BD & Matsumoto AM. (2012) Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab 97, 20502058.
  • Vermeulen A, Verdonck L & Kaufman JM. (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84, 36663672.
  • Vigen R, O'Donnell CI, Barón AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A, Woning G, Wierman ME, Plomondon ME, Rumsfeld JS & Ho PM. (2013) Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 310, 18291836.
  • Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S & Vanderschueren D. (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93, 27372745.
  • Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Boonen S, Vanderschueren D, Labrie F & Huhtaniemi IT; EMAS Group (2010). Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 363, 123135.
  • Xu L, Freeman G, Cowling BJ & Schooling CM. (2013) Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med 11, 108.